Self-Efficacy to Obtain Human Papillomavirus Vaccination among Indonesian Adolescent Girls.
Cervical cancer
Vaccination
adolescence
human papillomavirus
self-efficacy
Journal
Asian Pacific journal of cancer prevention : APJCP
ISSN: 2476-762X
Titre abrégé: Asian Pac J Cancer Prev
Pays: Thailand
ID NLM: 101130625
Informations de publication
Date de publication:
01 Mar 2022
01 Mar 2022
Historique:
received:
05
03
2021
entrez:
29
3
2022
pubmed:
30
3
2022
medline:
31
3
2022
Statut:
epublish
Résumé
This study aimed to examine self-efficacy to obtain the HPV vaccination among adolescent girls in Indonesia. Furthermore, factors affecting HPV vaccination self-efficacy was investigated. A cross-sectional study was conducted 337 among adolescent girls in junior high school (aged 12-15 years). Participants were recruited from four junior high schools in Yogyakarta using consecutive sampling. A self-administered questionnaire requested demographic information, knowledge of HPV and HPV vaccine and self-efficacy to obtain HPV vaccine. School teachers facilitate the data collection adolescent girls using the listed questionnaires. Data analysis used Pearson correlation, chi-squared tests and logistic regression analysis. As many as 50.1% of the adolescent girls reported high self-efficacy to obtain HPV vaccine and 57.9% reported high knowledge about HPV and HPV vaccine. There were significant correlations between self-efficacy and age, vaccination experience, recommendation from health care providers, parental support, social persuasion and anxiety. Parental support contributed to almost 18 times (95% CI:3.837 - 83.648; p<0.0001) while social persuasion was nearly 9 times (95% CI: 3.875-20.011; p<0.0001) more likely to predict the self-efficacy to obtain HPV vaccination. Parental support and social persuasion significantly predict self-efficacy to obtain HPV vaccination. Parental support is the main factor in the decision making of adolescent to obtain HPV vaccination.
Identifiants
pubmed: 35345348
doi: 10.31557/APJCP.2022.23.3.789
pmc: PMC9360927
pii:
doi:
Substances chimiques
Papillomavirus Vaccines
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
789-794Références
Public Health. 2014 Mar;128(3):268-73
pubmed: 24529635
Prev Med. 2017 Sep;102:24-30
pubmed: 28652087
Am J Obstet Gynecol. 2015 Jan;212(1):65.e1-5
pubmed: 24983684
Ann Behav Med. 2012 Oct;44(2):171-80
pubmed: 22547155
Asian Pac J Cancer Prev. 2016;17(S3):263-8
pubmed: 27165236
Health Psychol Rev. 2016 Jun;10(2):113-28
pubmed: 25117692
Pediatr Rev. 2017 Sep;38(9):443-445
pubmed: 28864741
J Korean Med Sci. 2017 Jan;32(1):130-134
pubmed: 27914142
Papillomavirus Res. 2016 Dec;2:122-127
pubmed: 29074171
J Youth Adolesc. 2016 Jun;45(6):1053-64
pubmed: 26847424
Prev Med. 2017 Jul;100:41-49
pubmed: 28389328
Hum Vaccin Immunother. 2016 Jun 2;12(6):1498-503
pubmed: 26934107
PLoS One. 2014 Mar 11;9(3):e90912
pubmed: 24618636